Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2020

01.02.2020 | Original Article

E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1

verfasst von: Yanping Wang, Xuemei Chen, Qiuyun Yang, Wenjing Tang, Yanjun Jia, Lina Zhou, Yunfei An, Zhiyong Zhang, Xuemei Tang, Xiaodong Zhao

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Activated PI3Kδ syndrome 1 is a primary immunodeficiency disease, usually caused by heterozygous mutations in PIK3CD. We aimed to identify the cause of homozygous mutation at c.G3061A (p.E1021K) in a patient and the effect of allele dose in this mutation.

Methods

Genomic DNA from the parent-child trio was analyzed by next-generation sequencing. We performed phenotypic analyses in the patient and in Pik3cdE1024K+/+ mice.

Results

The patient was a girl harboring a homozygous mutation for p.E1021K in PIK3CD. At the age of 2 months, she began experiencing respiratory tract infections and lymphoproliferation, accompanied by bronchiectasis and extensive atelectasis in the lungs. She suffered from Haemophilus influenzae and Cytomegalovirus infections and experienced restricted growth and development. Whole-exome sequencing showed a region that included PIK3CD, with loss of heterozygosity (LOH) in chromosome 1 of the patient. The patient had not inherited any allele from her father in the LOH region. Copy number variation analysis showed no changes in the patient’s father and the patient. Ultra-deep sequencing of genomic DNA from the patient’s mother showed that the mutant allele frequency for c.G3061A was 1.64%. Thus, the presence of segmental maternal uniparental disomy and maternal gonosomal mosaicism resulted in the homozygous mutation. Lymphadenopathy, differentiation of activated T cells, and follicular B cells lymphopenia were found to be more prominent in Pik3cdE1024+/+ mice than in Pik3cdE1024+/ mice.

Conclusion

This report showed the coexistence of uniparental disomy and mosaicism in PIK3CD. Some immunological features were seen to be allele dose-dependent in the presence of p.E1021K mutation.
Literatur
1.
Zurück zum Zitat Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342:866–71.CrossRef Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342:866–71.CrossRef
2.
Zurück zum Zitat Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3Kδ and primary immunodeficiencies. Nat Rev Immunol. 2016;16:702–14.CrossRef Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3Kδ and primary immunodeficiencies. Nat Rev Immunol. 2016;16:702–14.CrossRef
3.
Zurück zum Zitat Han JM, Patterson SJ, Levings MK. The role of the PI3K signaling pathway in CD4+ T cell differentiation and function. Front Immunol. 2012;3:1–12. Han JM, Patterson SJ, Levings MK. The role of the PI3K signaling pathway in CD4+ T cell differentiation and function. Front Immunol. 2012;3:1–12.
4.
Zurück zum Zitat Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139:597–606.e4.CrossRef Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139:597–606.e4.CrossRef
5.
Zurück zum Zitat Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2019. Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2019.
6.
Zurück zum Zitat Wang Y, Wang W, Liu L, Hou J, Ying W, Hui X, et al. Report of a Chinese cohort with activated Phosphoinositide 3-kinase δ syndrome. J Clin Immunol. 2018;38:854–63.CrossRef Wang Y, Wang W, Liu L, Hou J, Ying W, Hui X, et al. Report of a Chinese cohort with activated Phosphoinositide 3-kinase δ syndrome. J Clin Immunol. 2018;38:854–63.CrossRef
7.
Zurück zum Zitat Michalovich D, Nejentsev S. Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol. 2018;9:1–6.CrossRef Michalovich D, Nejentsev S. Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol. 2018;9:1–6.CrossRef
8.
Zurück zum Zitat Lougaris V, Baronio M, Moratto D, Tampella G, Gazzurelli L, Facchetti M, et al. A novel monoallelic gain of function mutation in p110δ causing atypical activated phosphoinositide 3-kinase δ syndrome (APDS-1). Clin Immunol. 2019;200:31–4.CrossRef Lougaris V, Baronio M, Moratto D, Tampella G, Gazzurelli L, Facchetti M, et al. A novel monoallelic gain of function mutation in p110δ causing atypical activated phosphoinositide 3-kinase δ syndrome (APDS-1). Clin Immunol. 2019;200:31–4.CrossRef
9.
Zurück zum Zitat Heurtier L, Lamrini H, Chentout L, Deau MC, Bouafia A, Rosain J, et al. Mutations in the adaptor-binding domain and associated linker region of p110δ cause activated PI3K-δ. syndrome 1 (APDS1). Haematologica. 2017;102:e278–81.CrossRef Heurtier L, Lamrini H, Chentout L, Deau MC, Bouafia A, Rosain J, et al. Mutations in the adaptor-binding domain and associated linker region of p110δ cause activated PI3K-δ. syndrome 1 (APDS1). Haematologica. 2017;102:e278–81.CrossRef
10.
Zurück zum Zitat Rae W, Gao Y, Ward D, Mattocks CJ, Eren E, Williams AP. A novel germline gain-of-function variant in PIK3CD. Clin Immunol. 2017;181:29–31.CrossRef Rae W, Gao Y, Ward D, Mattocks CJ, Eren E, Williams AP. A novel germline gain-of-function variant in PIK3CD. Clin Immunol. 2017;181:29–31.CrossRef
11.
Zurück zum Zitat Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF, et al. Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans. J Allergy Clin Immunol. 2017;140:1152–1156.e10.CrossRef Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF, et al. Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans. J Allergy Clin Immunol. 2017;140:1152–1156.e10.CrossRef
12.
Zurück zum Zitat Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE. Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A. 2017;114:1982–7.CrossRef Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE. Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A. 2017;114:1982–7.CrossRef
13.
Zurück zum Zitat Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142:970–973.e8.CrossRef Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142:970–973.e8.CrossRef
14.
Zurück zum Zitat Harel T, Yoon WH, Garone C, Gu S, Coban-Akdemir Z, Eldomery MK, et al. Recurrent De novo and Biallelic variation of ATAD3A, encoding a mitochondrial membrane protein, results in distinct neurological syndromes. Am J Hum Genet. 2016;99:831–45.CrossRef Harel T, Yoon WH, Garone C, Gu S, Coban-Akdemir Z, Eldomery MK, et al. Recurrent De novo and Biallelic variation of ATAD3A, encoding a mitochondrial membrane protein, results in distinct neurological syndromes. Am J Hum Genet. 2016;99:831–45.CrossRef
15.
Zurück zum Zitat Liu H, Tang XL, Liu JR, Li HM, Zhao SY. Clinical and genetic analysis for activated PI3K-δ syndrome by PIK3CD gene mutation. Chinese J Pediatr. 2016;54:698–702. Liu H, Tang XL, Liu JR, Li HM, Zhao SY. Clinical and genetic analysis for activated PI3K-δ syndrome by PIK3CD gene mutation. Chinese J Pediatr. 2016;54:698–702.
16.
Zurück zum Zitat Soler-Palacín P, Garcia-Prat M, Martín-Nalda A, Franco-Jarava C, Rivière JG, Plaja A, et al. LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Front Immunol. 2018;9:1–6.CrossRef Soler-Palacín P, Garcia-Prat M, Martín-Nalda A, Franco-Jarava C, Rivière JG, Plaja A, et al. LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Front Immunol. 2018;9:1–6.CrossRef
17.
Zurück zum Zitat Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview. Am J Med Genet Part C Semin Med Genet. 2010;154:329–34.CrossRef Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview. Am J Med Genet Part C Semin Med Genet. 2010;154:329–34.CrossRef
18.
Zurück zum Zitat Bravo García-Morato M, Nevado J, González-Granado LI, Sastre Urgelles A, Rodríguez Pena R, Ferreira CA. Chronic granulomatous disease caused by maternal uniparental isodisomy of chromosome 16. J Allergy Clin Immunol Pract. 2017;5:1146–8.CrossRef Bravo García-Morato M, Nevado J, González-Granado LI, Sastre Urgelles A, Rodríguez Pena R, Ferreira CA. Chronic granulomatous disease caused by maternal uniparental isodisomy of chromosome 16. J Allergy Clin Immunol Pract. 2017;5:1146–8.CrossRef
19.
Zurück zum Zitat Mensa-Vilaró A, Bravo García-Morato M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, et al. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases. J Allergy Clin Immunol. 2019;143:359–68.CrossRef Mensa-Vilaró A, Bravo García-Morato M, de la Calle-Martin O, Franco-Jarava C, Martínez-Saavedra MT, González-Granado LI, et al. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases. J Allergy Clin Immunol. 2019;143:359–68.CrossRef
20.
Zurück zum Zitat Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet Part C Semin Med Genet. 2014;166:397–405.CrossRef Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet Part C Semin Med Genet. 2014;166:397–405.CrossRef
21.
Zurück zum Zitat Puck JM, Pepper AE, Bedard PM, Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor γ-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest. 1995;95:895–9.CrossRef Puck JM, Pepper AE, Bedard PM, Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor γ-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest. 1995;95:895–9.CrossRef
22.
Zurück zum Zitat Pang X, Zheng X, Kong X, Chai Y, Wang Y, Qian H, et al. A homozygous MITF mutation leads to familial Waardenburg syndrome type 4. Am J Med Genet Part A. 2019;179:243–8.CrossRef Pang X, Zheng X, Kong X, Chai Y, Wang Y, Qian H, et al. A homozygous MITF mutation leads to familial Waardenburg syndrome type 4. Am J Med Genet Part A. 2019;179:243–8.CrossRef
23.
Zurück zum Zitat Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, et al. Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: a clinical and neuropathological study. J Neurol Sci. 2017;373:321–8.CrossRef Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, et al. Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: a clinical and neuropathological study. J Neurol Sci. 2017;373:321–8.CrossRef
24.
Zurück zum Zitat Fabrizi GM, Pellegrini M, Angiari C, Cavallaro T, Morini A, Taioli F, et al. Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-tooth disease type 1B. Neuromuscul Disord. 2006;16:183–7.CrossRef Fabrizi GM, Pellegrini M, Angiari C, Cavallaro T, Morini A, Taioli F, et al. Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-tooth disease type 1B. Neuromuscul Disord. 2006;16:183–7.CrossRef
25.
Zurück zum Zitat Edwards N, Olinger E, Adam J, Kelly M, Schiano G, Ramsbottom SA, et al. A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion. Nephrol Dial Transplant. 2017;32:1994–9.CrossRef Edwards N, Olinger E, Adam J, Kelly M, Schiano G, Ramsbottom SA, et al. A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion. Nephrol Dial Transplant. 2017;32:1994–9.CrossRef
26.
Zurück zum Zitat Madsen RR, Knox RG, Pearce W, Lopez S, Mahler-Araujo B, McGranahan N, et al. Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner. Proc Natl Acad Sci U S A. 2019;116:8380–9.CrossRef Madsen RR, Knox RG, Pearce W, Lopez S, Mahler-Araujo B, McGranahan N, et al. Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner. Proc Natl Acad Sci U S A. 2019;116:8380–9.CrossRef
27.
Zurück zum Zitat Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15:88–97.CrossRef Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15:88–97.CrossRef
Metadaten
Titel
E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1
verfasst von
Yanping Wang
Xuemei Chen
Qiuyun Yang
Wenjing Tang
Yanjun Jia
Lina Zhou
Yunfei An
Zhiyong Zhang
Xuemei Tang
Xiaodong Zhao
Publikationsdatum
01.02.2020
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2020
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00749-y

Weitere Artikel der Ausgabe 2/2020

Journal of Clinical Immunology 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.